CRYSTALLINE IMATINIB BASE AND PROCESS FOR PRODUCING THE SAME
PROBLEM TO BE SOLVED: To provide a crystalline imatinib base form I suitable for preparing an imatinib salt such as a mesylate salt, and a process for producing it. SOLUTION: The crystalline imatinib base form I characterized by the X-ray powder diffraction pattern that shows strong diffraction peak...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | IUSTAIN CARMEN ADIN ITAI FUTERMAN YURI |
description | PROBLEM TO BE SOLVED: To provide a crystalline imatinib base form I suitable for preparing an imatinib salt such as a mesylate salt, and a process for producing it. SOLUTION: The crystalline imatinib base form I characterized by the X-ray powder diffraction pattern that shows strong diffraction peaks at 2θ of 6.0, 17.2, 18.1, 18.7, 19.8, 20.9, 23.8, 24.3 and 25.2±0.2 degrees is provided. A process for preparing the imatinib salts from the crystalline imatinib base form I is also provided. COPYRIGHT: (C)2008,JPO&INPIT |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2007308494A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2007308494A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2007308494A3</originalsourceid><addsrcrecordid>eNrjZLBxDooMDnH08fH0c1Xw9HUM8fTzdFJwcgx2VXD0c1EICPJ3dg0OVnDzDwKxXUKdPf3cFUI8XBWCHX1deRhY0xJzilN5oTQ3g5Kba4izh25qQX58anFBYnJqXmpJvFeAkYGBubGBhYmliaMxUYoASb8p3g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CRYSTALLINE IMATINIB BASE AND PROCESS FOR PRODUCING THE SAME</title><source>esp@cenet</source><creator>IUSTAIN CARMEN ; ADIN ITAI ; FUTERMAN YURI</creator><creatorcontrib>IUSTAIN CARMEN ; ADIN ITAI ; FUTERMAN YURI</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a crystalline imatinib base form I suitable for preparing an imatinib salt such as a mesylate salt, and a process for producing it. SOLUTION: The crystalline imatinib base form I characterized by the X-ray powder diffraction pattern that shows strong diffraction peaks at 2θ of 6.0, 17.2, 18.1, 18.7, 19.8, 20.9, 23.8, 24.3 and 25.2±0.2 degrees is provided. A process for preparing the imatinib salts from the crystalline imatinib base form I is also provided. COPYRIGHT: (C)2008,JPO&INPIT</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071129&DB=EPODOC&CC=JP&NR=2007308494A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071129&DB=EPODOC&CC=JP&NR=2007308494A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>IUSTAIN CARMEN</creatorcontrib><creatorcontrib>ADIN ITAI</creatorcontrib><creatorcontrib>FUTERMAN YURI</creatorcontrib><title>CRYSTALLINE IMATINIB BASE AND PROCESS FOR PRODUCING THE SAME</title><description>PROBLEM TO BE SOLVED: To provide a crystalline imatinib base form I suitable for preparing an imatinib salt such as a mesylate salt, and a process for producing it. SOLUTION: The crystalline imatinib base form I characterized by the X-ray powder diffraction pattern that shows strong diffraction peaks at 2θ of 6.0, 17.2, 18.1, 18.7, 19.8, 20.9, 23.8, 24.3 and 25.2±0.2 degrees is provided. A process for preparing the imatinib salts from the crystalline imatinib base form I is also provided. COPYRIGHT: (C)2008,JPO&INPIT</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBxDooMDnH08fH0c1Xw9HUM8fTzdFJwcgx2VXD0c1EICPJ3dg0OVnDzDwKxXUKdPf3cFUI8XBWCHX1deRhY0xJzilN5oTQ3g5Kba4izh25qQX58anFBYnJqXmpJvFeAkYGBubGBhYmliaMxUYoASb8p3g</recordid><startdate>20071129</startdate><enddate>20071129</enddate><creator>IUSTAIN CARMEN</creator><creator>ADIN ITAI</creator><creator>FUTERMAN YURI</creator><scope>EVB</scope></search><sort><creationdate>20071129</creationdate><title>CRYSTALLINE IMATINIB BASE AND PROCESS FOR PRODUCING THE SAME</title><author>IUSTAIN CARMEN ; ADIN ITAI ; FUTERMAN YURI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2007308494A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>IUSTAIN CARMEN</creatorcontrib><creatorcontrib>ADIN ITAI</creatorcontrib><creatorcontrib>FUTERMAN YURI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>IUSTAIN CARMEN</au><au>ADIN ITAI</au><au>FUTERMAN YURI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CRYSTALLINE IMATINIB BASE AND PROCESS FOR PRODUCING THE SAME</title><date>2007-11-29</date><risdate>2007</risdate><abstract>PROBLEM TO BE SOLVED: To provide a crystalline imatinib base form I suitable for preparing an imatinib salt such as a mesylate salt, and a process for producing it. SOLUTION: The crystalline imatinib base form I characterized by the X-ray powder diffraction pattern that shows strong diffraction peaks at 2θ of 6.0, 17.2, 18.1, 18.7, 19.8, 20.9, 23.8, 24.3 and 25.2±0.2 degrees is provided. A process for preparing the imatinib salts from the crystalline imatinib base form I is also provided. COPYRIGHT: (C)2008,JPO&INPIT</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_JP2007308494A |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | CRYSTALLINE IMATINIB BASE AND PROCESS FOR PRODUCING THE SAME |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T03%3A59%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=IUSTAIN%20CARMEN&rft.date=2007-11-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2007308494A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |